Accelerate pharma scale-up with early automation integration
Bring automation, data, and process knowledge together earlier in development to reduce rework, shorten technology transfer timelines, and improve production readiness.
Scaling pharmaceutical processes from the laboratory to commercial production remains a significant challenge. Fragmented data, disconnected systems, and late-stage automation often create inefficiencies that can lead to rework, delays, and increased risk during technology transfer. As emerging therapies add complexity to manufacturing, organizations need a more connected approach to process development.
This article explores how early automation integration and unified data architecture can help pharmaceutical manufacturers create a smoother transition from R&D to production. Learn how standards-based automation, connected data, and modular process design improve visibility, support faster scale-up, and enable more efficient technology transfer across the product lifecycle.
Key takeaways
- Reduce rework during scale-up
- Accelerate technology transfer
- Improve production readiness
- Enable AI with connected data
- Increase flexibility with standards-based automation
- Reduce risk from lab to production
Successful scale-up requires more than process knowledge alone. Discover how integrating automation earlier in development and establishing a connected data foundation can help streamline technology transfer, enhance operational flexibility, and support long-term manufacturing success.